Join Dr. Guy Glover, a critical care physician at Guy’s and St Thomas’ NHS Foundation Trust in the U.K., and Kathleen Merkley, Senior Vice President of Professional Services at Health Catalyst, as they discuss key findings from a U.K. study, in which Dr. Glover was the lead investigator. The study assesses the widely used NEWS2 score versus a simple respiratory assessment, the Respiratory rate—Oxygenation (ROX) index, as a more sensitive predictor of deterioration among hospitalized patients with COVID-19. This will be set in a wider context of how to understand and optimize rapid response systems in hospitals for COVID-19 and beyond.
